Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PFGC✓SelectedUSD · PFGCGSK vs PFGC performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs PFGC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
PFGC return
+137.1%
Excess return
-90.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioPFGCExcessAlpha
1D-0.1%+0.7%-0.8%-0.2%
7D-1.3%+0.2%-1.5%-1.3%
30D+2.7%+14.5%-11.8%+0.9%
3M+2.7%+4.4%-1.7%+1.9%
6M+3.3%+16.7%-13.4%+1.3%
YTD+6.5%+24.6%-18.1%+3.3%
1Y+10.7%+17.8%-7.1%+8.0%
3Y+64.4%+81.6%-17.3%+50.1%
5Y+46.7%+144.1%-97.4%+29.5%
All+46.7%+137.1%-90.4%+29.5%

Cumulative growth

Daily Returns

Daily percentage return beside PFGC.

Daily Out/Under-Performance

Portfolio return minus PFGC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PFGC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded PFGC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling